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E-mail address: lkotula@gmail.comCoordination of actin cytoskeletal reorganization with growth and proliferation signals is a key cel-
lular process that is not fully understood. PI-3 kinase is one of the central nodes for distributing
growth and proliferation signals downstream from growth factor receptors to the nucleus. Although
PI-3 kinase function has been associated with actin cytoskeleton remodeling, satisfactory explana-
tions of the mechanisms mediating this regulation have been elusive. Here we propose that interac-
tion of the Abi1 protein with the p85 regulatory subunit of PI-3 kinase represents the link between
growth receptor signaling and actin cytoskeleton remodeling. This function of Abi1, which involves
WAVE complex, was initially observed in macropinocytosis, and may explain the coincident dysreg-
ulation of PI-3 kinase and actin cytoskeleton in cancer.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Dysregulation of the actin cytoskeleton is associated with virtu-
ally all stages of human cancer regardless of origin [1]. The acqui-
sition of speciﬁc knowledge of molecular mechanisms underlying
human cancer is key to devising speciﬁc diagnostic and treatment
strategies [2]. Delineation of precise mechanisms and of key
molecular players thus provides a rationale for future personalized
treatment of individuals [3]. Among current advances, consider-
able promise for anti-cancer treatment is offered by PI-3 kinase
inhibitors [4,5]. Anti-proliferative effects of PI-3 kinase inhibitors
have been associated with effects on actin cytoskeleton, suggesting
that the cytoskeleton might be the important target for the thera-
peutic effects of PI-3 kinase inhibitors in proposed therapies [5].
Although functional connections between actin cytoskeleton and
PI-3 kinase-dependent proliferation have been established, our
lack of knowledge of the mechanism makes it hard to explain or
therapeutically exploit this phenomenon. Nonetheless, recent ﬁnd-
ings suggest that the regulation involves interaction of PI-3 kinase
with WAVE complex (Fig. 1A), the major actin cytoskeleton regula-
tory complex, through its critical component, Abi1 [6] (Fig. 1B).chemical Societies. Published by E
Research in Developmental
0314, USA. Fax: +1 718 6982. Regulation of WAVE complex and PI-3 kinase
WAVE complexes are the major actin nucleation-promoting fac-
tors that regulate actin polymerization. In cells, WAVE complexes
consist of associations of ubiquitously expressed variants of 5 poly-
peptides: Abl interactor-1 (Abi1, Hssh3bp1), Rac1-associated pro-
tein 1 (Sra-1), Nck-associated protein 1 (Nap1), and WAVE2, as
well as a 9 kDa-peptide called Brck-1 or HSPC300 [7–9] (Fig 1B).
Except for Brck-1, which is a single copy gene, each of these pro-
teins is member of a protein family consisting of two or three genes
in mammals including alternatively spliced isoforms of some genes
[10]: Sra-1 and PIR121 (also known as Cyﬁp1 and Cyﬁp2), Nap1
and Hem1, Abi1, Abi2, and Abi3 (also called NESH), and WAVE1,
WAVE2, and WAVE3. Most of the isoforms have been shown to
assemble intoWAVE-complexes in comparable fashion [11]. WAVE
complex has been implicated in membrane rufﬂing, but there is
contradictory evidence as to which complexes regulate peripheral
(lamellipodia) vs. dorsal rufﬂing [12,13]. WAVE complexes are also
involved in cell motility and migration, cellular adhesion, cell-
to-cell communication, cell division [9,14–17], and participate in
immunological responses [18]. Thus, WAVE complexes are in-
volved in numerous processes requiring major actin cytoskeleton
reorganization and dynamics [19]. Importantly, dysregulation of
WAVE complex or its components is associated with human cancer
[20–25].
The critical role of Abi1 in dorsal rufﬂing identiﬁes Abi1 as a
major regulatory protein in macropinocytosis. Macropinocytosislsevier B.V. All rights reserved.
Fig. 1. Structural determinants of WAVE and PI-3 kinase complexes. (A) Anatomy of
WAVE complex. WAVE complex integral proteins include Rac1-associated protein 1
(Sra-1), Nck-associated protein 1 (Nap1), Abl interactor-1 (Abi1, Hssh3bp1), and
WAVE2, and Brck-1 or HSPC300 or their variants. Activation of WAVE complex
occurs upon conformational change leading to availability of VCA to bind Arp2/3
complex. WAVE complex has been implicated in multiple actin polymerization-
dependent cellular functions. (B) Domain structure of Abi1. Abi1 structural and
functional domains and identiﬁed binding regions for listed proteins or their
domains. WAVE-BD, WAVE domain binding region [64,77]; HHR, homeo-domain
homologous region; Abl-SH3-SH2, c-Abl kinase SH3-SH2 domain binding region
[65], PEST, PXXP-, Ser–rich, or PolyPro-rich, sequences rich in SH3 domain binding
consensus PXXP, serine or proline residues, respectively; SH3, Src homology 3
domain. Indicated binding sites for: Spectrin-SH3, Spectrin Src Homology 3 domain;
Eps8-SH3, Eps8 Src Homology 3 domain; p85-N-SH2, p85 regulatory subunit of
phosphoinositide-3 kinase; Abl-PRL, c-Abl kinase proline rich region, N-WASP and
mDia. Black arrows indicate identiﬁed tyrosine phosphorylation sites: pY213,
pY421, pY435, and pY506, which were identiﬁed to interact with p85-SH2 domains
[6,66]. (C) Autoinhibitory structure of PI-3 kinase. Linear depiction of inhibitory
interaction between subunits of PI-3 kinase. Top, p110 catalytic subunit (alpha or
beta) of PI-3 kinase and its subdomains: ABD, adaptor binding domain; RAS, Ras
binding domain; C2, C2 domain; Helical, helical domain; and Kinase, kinase/
catalytic domain. Bottom, p85 regulatory subnit of PI-3 kinase and its subdomains:
SH3, Src homology 3 domain; RhoGAP, Rho GTPase-related domain; N-SH2, N-
terminal Src homology 2 domain; iSH2, inter-SH2 domain and C-SH2, C-terminal
Src homology 2 domain. Arrows indicate inhibitory interactions between the
subunit subdomains. p110 beta has additional interaction involving the C-SH2 and
kinase domain but weaker iSH2-C2 interaction. Abi1 phosphopeptides can bind N-
SH2 and C-SH2 in vitro [6] raising the possibility of PI-3 kinase activation by
competing off- and thus alleviating with the inhibitory interaction imposed by p85
subunit.
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sive plasma membrane reorganization involving membrane ruf-
ﬂing followed by formation of an extended and polymerized
actin-rich structure, which is subsequently enclosed and internal-
ized as a macropinosome. Macropinocytosis is involved in nutrient
uptake [26]; It is normally upregulated following growth factor
and mitogenic agent stimulation [27–29] and pathologically
upregulated in cancer cell lines [30–37]. Fibroblasts lacking Abi1
have a signiﬁcant defect in dorsal rufﬂing and have downregulated
WAVE2 and WAVE1 complexes, but have upregulated Abi2 and
WAVE3 [38]. Dysregulation of WAVE complexes or its componentshas been associated with invasiveness in prostate cancer [39,40],
breast cancer [21], and epithelial tumorigenesis in general
[22,23]. Recycling of integrins through PDGF-regulated dorsal ruf-
ﬂes [41], which likely occurs through direct binding of Abi1 to al-
pha 4 integrin, as deﬁned in cells from the conventional Abi1 KO
mouse [42], links regulation of macropinocytosis to directional cel-
lular migration and cellular adhesion, and thus, to processes that
have been signiﬁcantly implicated in cancer tumorigenesis and
progression.
PI-3 kinase is dysregulated in human cancer, and its dysregula-
tion contributes to tumor progression. Thus, it is important to
understand the mechanism of its regulation [43,44]. PI-3 kinases
can be divided into two subclasses, class IA PI-3 kinases and class
IB PI-3 kinases. Class IA PI-3 kinases are activated by receptor tyro-
sine kinases, whereas class IB PI-3 kinases are activated by G-pro-
tein-coupled receptors [45]. Here, we are concerned with class IA
PI-3 kinases. Recent studies have shed considerable light on the
regulation of class IA PI-3 kinase activity [46]. PI-3 kinase activity
is regulated by autoinhibitory interactions between its subunits,
p110 and p85 [47]. The catalytic activity is mediated by p110,
p85 is the regulatory subunit. Structural studies have conﬁrmed
earlier functional observations that identiﬁed inhibitory interac-
tions between catalytic p110 and regulatory p85 subunits [48].
These interactions involve sub-domains of p85 including iSH2, C-
SH2, and N-SH2 domains, and sub-domains of p110 including C2,
helical, and the catalytic (kinase) domains (Fig. 1C). Interactions
between the C-SH2 domain of p85 and the catalytic subunit dif-
fered depending on the isoform of the kinase [49,50]. In particular,
the interaction of the p85 C-SH2 domain with the p110 kinase do-
main occurs in PI-3 kinase beta, but not in PI-3 kinase alpha. How-
ever, the interaction between the p85 iSH2 domain and the p110
C2 domain is weaker in PI-3 kinase beta than in PI-3 kinase alpha
[51]. Because of this latter observation, and despite the presence of
the additional inhibitory C-SH2-kinase domain interaction, there is
controversy as to whether PI-3 kinase beta is more constitutively
active than PI-3 kinase alpha [47]. Moreover, for the beta isoform,
ligands that disrupt the interaction between the C-SH2 domain and
the catalytic domain have the potential to activate PI-3 kinase, as
has been proposed for the N-SH2 domain in both PI3 kinase iso-
forms [52]. Data from our laboratory [6] and others [66] suggest
that members of the Abi protein family ﬁt the paradigm for such
regulatory ligands. We postulate that Abi1 regulates PI-3 kinase
activity through regulating the p85 SH2 domain interaction with
the catalytic p110 subunit.
WAVE complex integrity is central to its regulatory role in pro-
moting actin polymerization. Several candidate mechanisms of
regulation of WAVE complex have been proposed, all of which in-
volve integrity of the complex requiring the presence of all constit-
uents. This conclusion was conﬁrmed by in vitro reconstitution
studies of WAVE complex [53,54], siRNA studies in cultured cells
[55,56], and in cells with genetic inactivation of WAVE [57] or
Abi1 genes [38]. Downregulation or removal of any integral WAVE
complex protein leads to lower levels of speciﬁc WAVE complexes,
which results in reduced WAVE activity as assessed by directly
measuring actin polymerization in vitro, or by cellular motility
and peripheral and dorsal rufﬂe formation assays.
Actin polymerization requires active WAVE complex. Activation
of WAVE complex involves a conformational change of inactive
WAVE complex that renders the VCA domain available for interac-
tion with Arp 2/3 [58,59]. Structural studies have revealed that the
conformational change that releases intermolecular VCA from
sequestration is induced by Rac-GTP binding to an allosteric site
on the WAVE complex [58]. Full activation of WAVE complex re-
quires prenylated, activated Rac1 and the presence of acidic phos-
pholipids such as PIP3 [54]. PIP3 binds directly to the basic region
of WAVE [60,61]. In addition to promoting activity of WAVE com-
Fig. 2. Regulation of WAVE and PI-3 kinase by Abi1. (A) A model for regulation of WAVE complex by phosphotyrosine-dependent interaction of Abi1 with p85. Active WAVE
complex promotes actin polymerization upstream of Arp2/3 complex. Under non-phosphorylated conditions, WAVE complex is inactive, and all components are bound
within the complex. Activation of the complex requires binding of active, prenylated Rac1 and acidic phospholipids (such as PIP3), as well as serine phosphorylation of Abi1
[54]. The latter occurs downstream of Erk, which promotes WAVE complex activity [63]. Abl kinase is proposed to have a negative effect on WAVE complex activity in vitro
[64], although WAVE2 when phosphorylated on tyrosine 150 by Abl rescues membrane rufﬂing [78]. Abl-mediated phosphorylation of Abi1 leads to recruitment of Abi1 by
p85, which occurs through binding of phospho-Abi1 to N-SH2 and C-SH2 domains [6]. We demonstrated the feasibility of theWAVE to p85 shuttling hypothesis by expressing
an Abi1 Y213F mutant, which led to enhanced macropinocytic uptake and cell spreading activity in comparison to wild type controls [6]. We postulate that this result is due
to an increase in active WAVE complex as Abi1 Y213F, because of its reduced afﬁnity for p85, is shifted intoWAVE2 complex. (B) Diagram depicting a hypothetical mechanism
of reciprocal regulation of WAVE2 complex-dependent and PI-3 kinase pathways. The presence of Abi1 within intact WAVE complex promotes its function in actin
polymerization-dependent processes such as macropinocytosis and cellular adhesion. c-Abl-dependent tyrosine phosphorylation [6,65] leads to recruitment of phospho-Abi1
into a complex with p85 through an interaction with the p85 SH2 domain [6] leading to increased PI-3 kinase activity. This leads to enhanced levels of phospho-Akt resulting
in enhanced cellular proliferation.
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the activated WAVE complex [60]. It has been proposed that Arf
cooperates with Rac1 to activate WAVE complex, but the mecha-
nism of this regulation has not been fully elucidated [62].
Phosphorylation regulates WAVE complex and Abi1 function.
Serine phosphorylation of WAVE and Abi proteins has been found
in active WAVE complex suggesting a possible role of serine phos-
phorylation in WAVE activation [54]. This observation is consistent
with the ﬁnding that Erk-dependent serine phosphorylation of
Abi1 promotes cell motility [63]. The role of tyrosine phosphoryla-
tion in WAVE complex activation is not well deﬁned. Tyrosine-
phosphorylated Abi1 was not observed in the studies by Lebensohn
reporting serine phosphorylation. The action of c-Abl tyrosine ki-
nase was reported to abrogate WAVE complex in vitro [64], but
the mechanism of this regulation has not been determined. In con-
trast, phosphorylation of WAVE2 at tyrosine 150 was proposed to
promote activation of WAVE complex through an allosteric effect
relieving VCA inhibition [58]. The role of Abi1 tyrosine phosphory-
lation in WAVE complex regulation is possibly even more complex.
Abi1 is phosphorylated on several tyrosine residues in an Abl ki-
nase-dependent manner [65,66]. Phosphorylation of Abi1 tyrosine213 (pY213) also regulates Abl kinase activity [65]. Abi1-pY213
transmits downstream signals through interaction with PI-3 kinase
regulatory subunit p85 [6].
Analysis of an Abi1-Y213F mutant revealed a mechanism by
which Abi1 might regulate macropinocytosis. The Y213F mutation
blocked the interaction of Abi1 with the p85 subunit of PI-3 kinase,
resulting in enhanced macropinocytic uptake and abrogation of the
ability of Abl kinase to regulate uptake [6]. Of interest, tyrosine
phosphorylated Abi1 has not been detected in active WAVE com-
plex [54]. Thus, we propose that non-tyrosine-phosphorylated
Abi1 associates with WAVE complex, but tyrosine-phosphorylated
Abi1 does not (Fig. 2A). Upon tyrosine phosphorylation, Abi1 asso-
ciates with the p85 subunit of PI-3 kinase through several phos-
photyrosine interactions, which we identiﬁed by unbiased SH2
domain screening [6]. We postulate that the Abi1-p85 interaction
competes with the inhibitory interaction of p85 with the catalytic
subunit of PI-3 kinase, as recently conﬁrmed for phosphopeptides
interacting with the p85-SH2 domain [50]. This hypothesis to ex-
plain regulation of PI-3 kinase by Abi1 is consistent with results
from Abi1 siRNA knockdown studies, which demonstrated that
downregulation of Abi1 (putatively resulting in decreased PI-3 ki-
L. Kotula / FEBS Letters 586 (2012) 2790–2794 2793nase activity) causes decreased levels of phosphorylated Akt in
breast cancer cell lines [67]. Consistently with the proposed regu-
lation, enhanced levels of phospho-Akt also correlate with high
Abi1 expression in invasive breast cancer [21].
3. The shuttling hypothesis
Tyrosine phosphorylation of Abi1 potentially regulates WAVE
and PI-3 kinase complexes. The emerging consensus is that Abi1
participates in complexes with WAVE and PI-3 kinase p85. Based
on our results [6] and taking into consideration protein–protein
interactions, we postulate that interaction of p85 with Abi1 plays
an inhibitory role in actin polymerization. The interaction of p85
and Abi1, which is Abl kinase-dependent and phosphotyrosine-
dependent, occurs through the binding of the p85 SH2 domain to
tyrosine phosphorylated Abi1. Our single-site afﬁnity analysis
suggests that the interaction between Abi1 and p85 involves coop-
erative binding of multiple Abi1 phosphotyrosines with sites in the
N-SH2 and C-SH2 domains of p85 [6]. p85 also interacts with Abi1
through a non-phosphorylation-dependent binding [6], most likely
involving the SH3 domain. These ﬁndings suggest that p85-Abi1
binding is competitive with Abi1 interactions with WAVE complex
components and precludes participation of tyrosine phosphory-
lated Abi1 in WAVE complex. The critical function of Abi1 in WAVE
complex [38], therefore, is predicted to be negatively regulated by
p85 binding. The fact that tyrosine phosphorylated Abi1 was not
detected in WAVE complex suggests that the phosphorylation sta-
tus of Abi1 determines its location—when phosphorylated, Abi1 is
complexed with p85-PI-3 kinase (although we cannot formally
exclude the presence of p85-Abi1 complexes independent from
the catalytic domain and similar to sequestration complexes previ-
ously observed with p85-IRS-1 [68]), and when non-phosphory-
lated, Abi1 is bound by the WAVE complex [54]. The resultant
‘‘shuttling’’ of Abi1 between WAVE complex and p85 (Fig. 2B) is
consistent both with enhanced actin polymerization resulting from
WAVE complex/Arp2/3 activity, and with increased localized PIP3
content resulting from enhanced PI-3 kinase activity, as occurs in
macropinocytic cups [69,70]. These studies and other biological
evidence [60,61,66,71] indicate that WAVE and Abi1-p85-PI-3 ki-
nase complexes are not mutually exclusive but work together to
promote actin polymerization-dependent and PIP3-dependent
processes. Importantly, mutations affecting the proposed mecha-
nism would likely affect the relative amount of the complexes,
and thus, would alter the dynamic balance between actin polymer-
ization and PI-3 kinase function. This effect would result in altered
PIP3 production, abnormal signaling, and tumorigenic growth.
Oncogenic mutations involving the p85 C-SH2 domain have been
observed in mammalian cancer [72]. Murine lymphomas contain
deletions of the C-terminal region comprising the entire C-terminal
SH2 domain [73]; human ovarian and colon cancer contain smaller
deletions immediately upstream of the C-SH2 domain [74]. By
modeling the LNCaP tumorigenic mutation, i.e., the heterozygous
loss of Abi1-pY213 [22], we were able to compare actin polymeri-
zation-dependent macropinocytosis in the context of interaction
with p85. We have shown that mutation of the critical Abi1 tyro-
sine 213, which is responsible for the p85-C-terminal SH2 domain
interaction, results in increased macropinocytosis [6], which is
consistent with enhanced WAVE complex activity.
4. Concluding remarks
We propose that this regulation might be generalized to differ-
ent functions ascribed to the WAVE complex and Abi1, and might
be important for coordinated regulation of actin cytoskeleton
downstream of WAVE complex and PI-3 kinase activity. In additionto macropinocytosis, cell-to-cell adhesion requires WAVE function
[75,76]. PI-3 kinase activity is required for coincidental prolifera-
tion and mitogenic signaling through PIP3 production. Under-
standing the role of Abi1 in these regulatory processes should
help to deﬁne mechanisms for coordinated actin polymerization
and cellular proliferation, which are required for proper spatiotem-
poral regulation of mitogenic and actin-dependent signaling
events, which are dysregulated in human cancer.
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